Kilohertz frequency electrical block of afferent vagus nerve pathways allows targeted stimulation to reduce inflammation in vivo
Is a treatment only making things better or maybe also making some things a little worse?
That can be a nagging question in some medical decisions, where side effects are possible. But researchers at the Georgia Institute of Technology have figured out a way to keep what helps, while blocking what harms, in a therapy to fight serious chronic inflammatory diseases.
It’s simple and works a little like a pacemaker: An implanted device electrically stimulates the vagus nerve, but, in addition, inhibits unwanted nerve activity in a targeted manner.
Forms of vagus nerve stimulation treatment have already been successfully tested in humans by private industry with the intent to market them to patients. But the innovation by Georgia Tech researchers of adding an inhibiting signal could increase the clinical efficacy and therapeutic benefit of existing treatments.
Temporarily snipping a nerve
“We use an electrode with a kilohertz frequency that blocks unwanted nerve conduction in addition to the electrode that stimulates nerve activity,” said principal investigator Robert Butera, a professor jointly appointed in Georgia Tech’s School of Electrical and Computer Engineering and the Wallace H. Coulter Dept. of Biomedical Engineering. “We’ve arranged the two near each other, so the blocking electrode forces the stimulation from the stimulating electrode to only go in one direction.”
The researchers’ innovation could theoretically by implemented relatively quickly by augmenting existing clinical devices. So far, tests in rats have returned very encouraging results, and they have been achieved without taking more drastic measures notable in other experiments to optimize this kind of treatment – such as a vagotomy, the cutting of part of the vagus.
“The original studies in animals on the anti-inflammatory benefits of vagus nerve stimulation resorted to nerve transections to achieve directional stimulation as well as boost effectiveness of nerve stimulation. But cutting the vagus is not clinically viable – due to the multitude of vital bodily functions it monitors and regulates. Our approach provides the same therapeutic benefit, but is also immediately reversible, controllable, and clinically feasible,” said lead researcher Yogi Patel, a bioengineering graduate student.
“We call it a virtual vagotomy,” Butera said.
Patel, Butera and former Georgia Tech researchers Tarun Saxena and Ravi V. Bellamkonda, published the results of their study in the journal Nature Scientific Reports on Thursday, January 5, 2016. The research was funded by the National Institutes of Health and the Ian’s Friends Foundation.
Vagus nerve: What is it?
To understand how this new bioelectronic fine-tuning works, let’s start with the vagus nerve itself.
It lies outside the spinal column and runs in two parts down the front of your neck on either side. It’s easy to forget about because, though it does help you feel some limited sensations like pain and heat from a handful of internal organs, those sensations are not as blatant and common as when you reach out and touch something with your hand.
Your voluntary, or somatic, nervous system is responsible for the reaching, touching, and feeling, and the vagus nerve belongs to your involuntary nervous system – actually called the autonomic nervous system. Though you may experience the effects less consciously, you couldn’t survive without a vagus.
“The vagus nerve conveys an incredible amount of information related to the state and function of the visceral organs – your digestive tract, your heart, your lungs, information about the nutrients you eat – anything required for homeostasis (physiological balance),” Patel said.
The vagus nerve is the lifeline between the vital function control centers of your brain and your visceral organs, passing messages constantly between your hypothalamus and organs to control things like pulse and respiration, the lubrication of sinuses, and the limiting of immune response.
Inflammation: What role does the vagus nerve play?
That last one is where inflammation comes in. When the immune system becomes hyperactive, it can attack not just pathogens but also healthy tissue, as with patients suffering from diseases such as rheumatoid arthritis, irritable bowel syndrome or Crohn’s disease. Drug-based therapies often fail to significantly benefit them.
The two parts of the autonomic (involuntary) nervous system — the sympathetic and the parasympathetic — strongly influence your immune system. The vagus nerve belongs to the parasympathetic.
“It’s like a seesaw system. Your sympathetic nervous system helps kick the immune system on, and the parasympathetic nervous system tempers it,” Patel said.
Electrical stimulation is good: Any downsides?
Stimulating the vagus nerve supports that tempering effect, but it can also somewhat excite the part of the nervous system that stimulates the immune response, which is counterproductive.
“Every circuit has a path coming from the brain and one going to the brain, and when you stimulate electrically, you usually have no control over which one you get. You usually get both.” Patel said. These paths are often in the same nerve being stimulated.
The path leaving the brain and going toward other organs, called the efferent pathway, is the one to stimulate to help relieve chronic inflammatory conditions. The one going to the brain, called the afferent pathway, if stimulated, leads eventually to the hypothalamus, a pea-sized region in the center of the brain, which triggers a chain of hormonal responses, eventually releasing cytokines, messaging molecules that promote inflammation.
“You get a heightened inflammatory response when you stimulate the afferent pathways, which are actively conveying information about your internal state and trigger the immune system when necessary,” Patel said. “And if a patient is already in a hyperactive immune state, you don’t want to push that even more.”
“When chronically inflamed, the body essentially thinks it’s in attack mode the entire time,” Patel said. “So, the ability to dampen the loop that results in more and more cytokines being produced is one way to shut down that cyclic process of more and more inflammation.”
Stimulating downward (efferent), while blocking upward (afferent) vagus nerve activity keeps the good effect while preventing possible bad effects. In animals that received this treatment, blood tests showed that inflammation markedly decreased. Most importantly, this treatment can be turned on or off, and be tuned to the needs of each patient.
Receive an email update when we add a new INFLAMMATION article.
The Latest on: Inflammation
via Google News
The Latest on: Inflammation
- The inflammation-busting ACV tonic Massy Arias blends up in the mornings on November 12, 2018 at 12:57 pm
Doing your skin-care regimen twice a day—once in the morning and once before bed—is pretty standard. But having a regular workout routine shakes everything up and adds more to the equation. After swea... […]
- Subclinical Heart Inflammation Seen in RA on November 12, 2018 at 10:36 am
A study using 18-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-CT) found that rheumatoid arthritis (RA) disease activity was correlated with more myocardial inflammation ... […]
- New Findings from Pluristem’s Phase II IC study: PLX-PAD Cells Significantly Improves Blood Glucose Control (HbA1c) and Reduce Chronic Inflammation on November 12, 2018 at 3:30 am
Additional analysis of the Phase II IC data confirmed the optimal dosing regimen of PLX-PAD in the treatment of peripheral arterial diseases (PAD) - two administrations of 300 million cells, each orig... […]
- AHA: Targeting Inflammation With Methotrexate Flops for CV Prevention on November 10, 2018 at 2:04 pm
CHICAGO -- Low-dose methotrexate given to reduce inflammation had no impact on cardiovascular events in high-risk but stable atherosclerosis, the CIRT randomized trial showed. A weekly dose of 15 to 2... […]
- Generic arthritis drug comes up short against inflammation in heart disease on November 10, 2018 at 1:51 pm
Giving a generic anti-inflammatory drug widely used to treat rheumatoid arthritis to people who previously had a heart attack or stroke worked no better than placebo in preventing another cardiovascul... […]
- What fights inflammation, boosts collagen, and relieves pain? Echinacea—and that’s only half its health benefits on November 7, 2018 at 11:25 pm
There are so many supplements that you could be taking at any given time—for your skin, for your hair, for your bloat, or even for better sleep, that it can become confusing to remember which does wha... […]
- Inflammation Can Steal Your Sleep on November 7, 2018 at 1:31 pm
The circadian rhythm, the body’s natural time-keeper, when kept in good working order can help to sustain a healthy state. When the circadian rhythm is altered any of the many contributing factors, th... […]
- How Reducing Inflammation Can Help Manage Psoriasis on November 7, 2018 at 8:03 am
Although the exact cause of psoriasis is still a matter of debate in the medical world, a theory that’s backed up by an ever-increasing amount of research is that inflammation in the body can lead to ... […]
- The Daily Biotech Pulse: EyePoint Licenses Eye Inflammation Drug, Insys Strategic Review Of Opioid Assets, Neos Offering on November 6, 2018 at 4:04 am
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Nov. 5) Allakos Inc (NASDAQ: ALLK) Allogene Therapeutics Inc ... […]
via Bing News